Stock jumps on data: Shares rose 14% after Phase 1 results showed strong immune responses and no serious safety issues for Moderna’s hantavirus vaccine. Platform potential: Analysts see the results as ...
5y
Moderna
The Moderna Innovation and Technology Centre in Harwell is now fully operational. The NHS Covid spring booster campaign is under way, but vaccines are also available privately. The easily spreadable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results